A phase II study of oral azacitidine (CC-486) in combination with pembrolizumab (PEMBRO) in patients with metastatic melanoma (MM).
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Emily Keung, Elizabeth M. Burton, Rodabe Navroze Amaria, Isabella Claudia Glitza, Sapna Pradyuman Patel, Adi Diab, Cassian Yee, Michael K Wong, Wen-Jen Hwu, Patrick Hwu, Scott Eric Woodman, Michael T. Tetzlaff, Denai Milton, Kristen Perez, Michael A. Davies, Kunal Rai, Jennifer Ann Wargo, Hussein Abdul-Hassan Tawbi
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2889826792